Aravive Biologics, Inc. — Form D

Aravive Biologics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-25. The offering totals $363K, of which $363K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-07-25
• Form: D
• Accession: 0001213900-17-007890
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $363K
• Amount sold: $363K
• Minimum investment: $363K
• Investors: 1
• Date of first sale: 2017-07-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-291420

Issuer

• Name: Aravive Biologics, Inc.
• CIK: 0001710436
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: LYONDELLBASELL TOWER, HOUSTON, TX, 77010
• Phone: 936-355-1910

Officers, directors & promoters (9)

More

• CIK 1710436 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search